ASR-2001
| Clinical data | |
|---|---|
| Other names | ASR2001; 2CB-5PrO; 2CB-5-PrO; 5-PrO-2C-B; 4-Bromo-2-methoxy-5-propoxyphenethylamine |
| Routes of administration | Oral |
| Drug class | Non-hallucinogenic serotonin 5-HT2A receptor and 5-HT1B receptor agonist |
| ATC code |
|
| Pharmacokinetic data | |
| Onset of action | 1–1.5 hours |
| Duration of action | 8–10 hours |
| Identifiers | |
| |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C12H18BrNO2 |
| Molar mass | 288.185 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
ASR-2001, also known as 2CB-5PrO or as 4-bromo-2-methoxy-5-propoxyphenethylamine, is a non-hallucinogenic serotonin receptor agonist of the phenethylamine, 2C, and TWEETIO families which is under development for the treatment of psychiatric disorders. It is the TWEETIO analogue of 2C-B in which the 5-methoxy group is replaced with a 5-propoxy group. The drug is taken orally.